GT201200335A - Procedimiento para la preparacion de diàcido 3,6.9- triaza-3,6,9-tris(carboximetil) -4-(4-etoxibencil)-undecanoico cristitalino y el uso para la preparacion de promovisto - Google Patents
Procedimiento para la preparacion de diàcido 3,6.9- triaza-3,6,9-tris(carboximetil) -4-(4-etoxibencil)-undecanoico cristitalino y el uso para la preparacion de promovistoInfo
- Publication number
- GT201200335A GT201200335A GT201200335A GT201200335A GT201200335A GT 201200335 A GT201200335 A GT 201200335A GT 201200335 A GT201200335 A GT 201200335A GT 201200335 A GT201200335 A GT 201200335A GT 201200335 A GT201200335 A GT 201200335A
- Authority
- GT
- Guatemala
- Prior art keywords
- preparation
- etoxibencil
- triaza
- tris
- carboximetil
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C227/14—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof
- C07C227/18—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof by reactions involving amino or carboxyl groups, e.g. hydrolysis of esters or amides, by formation of halides, salts or esters
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C227/38—Separation; Purification; Stabilisation; Use of additives
- C07C227/40—Separation; Purification
- C07C227/42—Crystallisation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
- C07C229/10—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings
- C07C229/16—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings to carbon atoms of hydrocarbon radicals substituted by amino or carboxyl groups, e.g. ethylenediamine-tetra-acetic acid, iminodiacetic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/26—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having more than one amino group bound to the carbon skeleton, e.g. lysine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/34—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
- C07C229/36—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings with at least one amino group and one carboxyl group bound to the same carbon atom of the carbon skeleton
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Crystallography & Structural Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
LA PRESENTE INVENCIÓN SE REFIERE A UN PROCEDIMIENTO PARA LA PREPARACIÓN DE DIÁCIDO 3,6,9-TRIAZA-3,6,9-TRIS(CARBOXIMETIL)-4-(4-ETOXIBENCIL)-UNDECANOICO CRISTALINO POR SAPONIFICACIÓN DE ÉSTER DI-TER-BUTÍLICO DEL DIÁCIDO 3,6,9-TRIAZA-3,6,9-TRIS(TER.-BITPXOCARBOMETIL)-4-(4-ETOXIBENCIL)-UNDECANOICO EN UNA SOLUCIÓN ACUOSA DE HIDRÓXIDO DE METAL ALCALINO Y EL USO DE DIÁCIDO 3,6,9-TRIAZA-3,6,9-TRIS(CARBOXIMETIL)-4-(4-ETOXIBENCIL)-UNDECANOICO PARA LA PREPARACIÓN DEL COMPLEJO DE GADOLINIO DE DIÁCIDO 3,6,9-TRIAZA-3,6,9-TRIS(CARBOXIMETIL)-4-(4-ETOXIBENCIL)-UNDECANOICO [(GD-EOB-DTPA)=PRIMOVIST®]
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE201010023890 DE102010023890A1 (de) | 2010-06-11 | 2010-06-11 | Verfahren zur Herstellung kristalliner 3,6,9-Triaza-3,6,9-tris(carboxymethyl)-4-(ethoxybenzyl)-undecandinsäure und die Verwendung zur Herstellung von Primovist |
BRPI1002466 BRPI1002466A2 (pt) | 2010-07-19 | 2010-07-19 | processo para preparação de diácido 3,6,9-triaza-3,6,9-tris(carboximetil)-4-(4-etoxibenzil)-u ndecánico cristalino e seu uso para preparação de primovist« |
Publications (1)
Publication Number | Publication Date |
---|---|
GT201200335A true GT201200335A (es) | 2014-03-25 |
Family
ID=45098458
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GT201200335A GT201200335A (es) | 2010-06-11 | 2012-12-11 | Procedimiento para la preparacion de diàcido 3,6.9- triaza-3,6,9-tris(carboximetil) -4-(4-etoxibencil)-undecanoico cristitalino y el uso para la preparacion de promovisto |
Country Status (23)
Country | Link |
---|---|
US (1) | US20130158241A1 (es) |
EP (1) | EP2580184A2 (es) |
JP (1) | JP2013531643A (es) |
KR (1) | KR20130111513A (es) |
CN (1) | CN103068790A (es) |
AU (1) | AU2011263890A1 (es) |
CA (1) | CA2801968A1 (es) |
CL (1) | CL2012003497A1 (es) |
CO (1) | CO6650345A2 (es) |
CR (1) | CR20120627A (es) |
CU (1) | CU20120168A7 (es) |
EC (1) | ECSP12012335A (es) |
GT (1) | GT201200335A (es) |
IL (1) | IL223553A0 (es) |
MA (1) | MA34304B1 (es) |
MX (1) | MX2012014490A (es) |
PE (1) | PE20130458A1 (es) |
RU (1) | RU2012157539A (es) |
SG (1) | SG186259A1 (es) |
TN (1) | TN2012000585A1 (es) |
TW (1) | TW201206876A (es) |
WO (1) | WO2011154333A2 (es) |
ZA (1) | ZA201300256B (es) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103420862B (zh) * | 2012-05-16 | 2015-04-22 | 齐鲁制药有限公司 | 一种钆塞酸二钠中间体化合物的金属盐、其晶型及制备方法 |
CN104672099A (zh) * | 2013-11-27 | 2015-06-03 | 山东富创医药科技有限公司 | 一种新的钆塞酸二钠中间体的制备方法 |
CN104130146B (zh) * | 2014-07-31 | 2016-03-02 | 苏州昊帆生物科技有限公司 | (4s)-3,6,9-三氮杂-3,6,9-三(羧甲基)-4-(4-乙氧基苄基)十一烷二酸的制备方法 |
US11149041B2 (en) | 2016-05-30 | 2021-10-19 | Biophore India Pharmaceuticals Pvt. Ltd. | Process for the preparation of gadolinium complex of (4S)-4-(4-ethoxybenzyl)-3,6,9-tris(carboxylatomethyl)-3,6,9-triazaundecanedioic acid disodium (Gadoxetate disodium) |
CN109851516B (zh) * | 2019-01-28 | 2020-10-02 | 湖北天舒药业有限公司 | 用于钆系造影剂中叔丁酯的水解方法 |
CN115876898B (zh) * | 2021-09-27 | 2024-10-01 | 长沙创新药物工业技术研究院有限公司 | 一种聚乙二醇修饰剂的制备及纯度测定方法 |
CN115043747B (zh) * | 2022-08-15 | 2022-11-25 | 康瑞鑫(天津)药物研究院有限公司 | 卡洛酸三钠的析晶方法及制备的卡洛酸三钠晶体 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3640708C2 (de) | 1986-11-28 | 1995-05-18 | Schering Ag | Verbesserte metallhaltige Pharmazeutika |
DE3922005A1 (de) | 1989-06-30 | 1991-01-10 | Schering Ag | Derivatisierte dtpa-komplexe, diese verbindungen enthaltende pharmazeutische mittel, ihre verwendung und verfahren zu deren herstellung |
HUT77553A (hu) * | 1994-11-30 | 1998-05-28 | Schering Aktiengesellschaft | Eljárás fémeket tartalmazó kelát komplexek alkalmazására a máj és az epe röntgendiagnosztikájában |
DE19712012A1 (de) * | 1997-03-13 | 1998-09-24 | Schering Ag | Verfahren zur Herstellung kristalliner 3,6,9-Triaza-3,6-9-tris(carboxymethyl)-4-(4- ethoxybenzyl)-undecandisäure |
-
2011
- 2011-06-06 AU AU2011263890A patent/AU2011263890A1/en not_active Abandoned
- 2011-06-06 RU RU2012157539/04A patent/RU2012157539A/ru not_active Application Discontinuation
- 2011-06-06 JP JP2013513641A patent/JP2013531643A/ja not_active Withdrawn
- 2011-06-06 MA MA35444A patent/MA34304B1/fr unknown
- 2011-06-06 WO PCT/EP2011/059243 patent/WO2011154333A2/de active Application Filing
- 2011-06-06 MX MX2012014490A patent/MX2012014490A/es not_active Application Discontinuation
- 2011-06-06 PE PE2012002300A patent/PE20130458A1/es not_active Application Discontinuation
- 2011-06-06 SG SG2012090684A patent/SG186259A1/en unknown
- 2011-06-06 CN CN2011800388543A patent/CN103068790A/zh active Pending
- 2011-06-06 KR KR1020137000174A patent/KR20130111513A/ko not_active Application Discontinuation
- 2011-06-06 EP EP11724612.4A patent/EP2580184A2/de not_active Withdrawn
- 2011-06-06 US US13/703,579 patent/US20130158241A1/en not_active Abandoned
- 2011-06-06 CA CA2801968A patent/CA2801968A1/en not_active Abandoned
- 2011-06-10 TW TW100120431A patent/TW201206876A/zh unknown
-
2012
- 2012-12-10 TN TNP2012000585A patent/TN2012000585A1/en unknown
- 2012-12-11 CU CU2012000168A patent/CU20120168A7/es unknown
- 2012-12-11 CL CL2012003497A patent/CL2012003497A1/es unknown
- 2012-12-11 GT GT201200335A patent/GT201200335A/es unknown
- 2012-12-11 IL IL223553A patent/IL223553A0/en unknown
- 2012-12-11 CO CO12224294A patent/CO6650345A2/es unknown
- 2012-12-11 EC ECSP12012335 patent/ECSP12012335A/es unknown
- 2012-12-11 CR CR20120627A patent/CR20120627A/es unknown
-
2013
- 2013-01-10 ZA ZA2013/00256A patent/ZA201300256B/en unknown
Also Published As
Publication number | Publication date |
---|---|
KR20130111513A (ko) | 2013-10-10 |
WO2011154333A3 (de) | 2012-02-16 |
IL223553A0 (en) | 2013-03-05 |
EP2580184A2 (de) | 2013-04-17 |
CO6650345A2 (es) | 2013-04-15 |
AU2011263890A1 (en) | 2013-01-24 |
ZA201300256B (en) | 2014-06-25 |
ECSP12012335A (es) | 2012-12-28 |
MX2012014490A (es) | 2013-02-07 |
MA34304B1 (fr) | 2013-06-01 |
RU2012157539A (ru) | 2014-07-20 |
US20130158241A1 (en) | 2013-06-20 |
CU20120168A7 (es) | 2013-04-19 |
CL2012003497A1 (es) | 2013-03-22 |
TN2012000585A1 (en) | 2014-04-01 |
TW201206876A (en) | 2012-02-16 |
CR20120627A (es) | 2013-03-13 |
CA2801968A1 (en) | 2011-12-15 |
SG186259A1 (en) | 2013-01-30 |
JP2013531643A (ja) | 2013-08-08 |
CN103068790A (zh) | 2013-04-24 |
PE20130458A1 (es) | 2013-04-11 |
WO2011154333A2 (de) | 2011-12-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR117799A2 (es) | Sal(es) de dimetil-amida del ácido 7-ciclopentil-2-(5-piperazin-1-il-piridin-2-il-amino)-7h-pirrolo-[2,3-d]-pirimidin-6-carboxílico y procesos para su elaboración | |
GT201200335A (es) | Procedimiento para la preparacion de diàcido 3,6.9- triaza-3,6,9-tris(carboximetil) -4-(4-etoxibencil)-undecanoico cristitalino y el uso para la preparacion de promovisto | |
NZ704662A (en) | Crystalline forms of the prolyl hydroxylase inhibitor [(4-hydroxy-1-methyl-7-phenoxy-isoquinoline-3-carbonyl)-amino]-acetic acid | |
GT201400136A (es) | Compuestos y métodos de benzaldehído substituído para su uso en incrementar la oxigenación de los tejidos | |
EA201391392A1 (ru) | Синтетические наноносители с осмотически опосредованным высвобождением | |
GT201400033A (es) | Pirimidinas anilladas sustituidas y uso de las mismas | |
PE20141406A1 (es) | 4-(8-metoxi-1-((1-metoxipropan-2-il)-2-(tetrahidro-2h-piran-4-il)-1h-imidazo[4,5-c]quinolin-7-il)-3,5-dimetilisoxazol y su uso como inhibidor bromodominio | |
ECSP10010295A (es) | Formulacion de anticuerpo | |
CO6771428A2 (es) | Composición efervescente en forma sólida para uso en aplicaciones vaginales para el tratamiento de infecciones vaginales | |
CR20130001A (es) | Derivados de indolizina, su procedimiento de preparación y su aplicación en terapéutica | |
DOP2013000244A (es) | Triazolopiridinas | |
MY159492A (en) | Solid pharmaceutical formulation with delayed release | |
UY32052A (es) | 5-aminopirazoles sustituidos y uso de los mismos | |
CL2012003458A1 (es) | Vector que comprende un polipeptido antigénico de campylobacter; composicion farmacéutica que comprende dicho vector; uso del vector para mejorar respuesta inmune del sujeto al polipéptido antigénico. | |
CO7160080A2 (es) | Composiciones lipídicas de racecadotrillo | |
AR089269A1 (es) | Composiciones para el cuidado oral | |
CO6741197A2 (es) | Proteína de fusión robo1-fc para uso en el tratamiento del hepatocarcinoma | |
CR11869A (es) | 7-sulfanilmetil-, 7-sulfinilmetil- y 7-sulfonilmetilindoles sustituidos y el uso de los mismos | |
CO6400226A2 (es) | Micrólido anti-inflamatorio | |
CL2013000335A1 (es) | Forma altamente cristalina de valsartan; proceso para prepararla; composicion farmaceutica que la comprende y uso en el tratamiento de la hipertension. | |
EP3138850B8 (en) | Compositions containing deoxycholic acid and 10% deionized water in ethanol, directed to the purification of deoxycholic acid | |
DOP2012000228A (es) | Procedimiento para la preparación de 2-(ciclohexilmetil)-n-{2-[(2s)-1-metilpirrolidin-2-il]etil}-1,2,3,4-tetrahidroisoquinolin-7-sulfonamida | |
CL2008001280A1 (es) | Composicion farmaceutica que comprende una sal de aminoacido n-halogenado; procedimiento de preparacion; y su uso como antimicrobiano. | |
AR089079A1 (es) | Formulacion de anticuerpo anti-cd44 | |
PE20151432A1 (es) | Formulaciones de lorazepam de liberacion sostenida |